|
|
|
Volumn 11, Issue 8 SUPPL., 1997, Pages 11-14
|
|
Docetaxel: Today's results and tomorrow's promises
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EDATREXATE;
ETOPOSIDE;
FLUOROURACIL;
GEMCITABINE;
MELPHALAN;
METHOTREXATE;
MITOMYCIN C;
NAVELBINE;
PACLITAXEL;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
TAMOXIFEN CITRATE;
VINBLASTINE;
ANTINEOPLASTIC ACTIVITY;
BREAST CARCINOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG MECHANISM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
MAXIMUM ALLOWABLE CONCENTRATION;
MULTICENTER STUDY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CARBOPLATIN;
CISPLATIN;
CLINICAL TRIALS;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0030812326
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (10)
|
